# miRNA gene mutations commonly disrupt the proper functioning of miRNA genes

**Authors:** Magdalena Machowska, Natalia Szostak, Adrian Tire, Wladyslaw Wegorek, Malwina Suszynska, Arkadiusz Kajdasz, Paulina Galka-Marciniak, Anna Philips, Piotr Kozlowski

PMC · DOI: 10.1126/sciadv.aea6079 · Science Advances · 2026-02-18

## TL;DR

This study shows that mutations in miRNA genes often disrupt their function, potentially leading to disease.

## Contribution

The study identifies how somatic mutations in miRNA genes affect miRNA processing and function using cancer genome data.

## Key findings

- Many miRNA gene mutations disrupt mature miRNA levels and isomiR profiles.
- Deleterious mutations destabilize miRNA precursor structures.
- Mutations in disease-related miRNA genes may be pathogenic.

## Abstract

A growing number of mutations are being identified in the noncoding genome, including microRNA (miRNA) genes; however, little is known about the consequences of these mutations and how harmful they are to the functioning of miRNA genes. To evaluate the effects of miRNA gene mutations, we took advantage of a large collection of somatic mutations identified in miRNA genes in >10,000 The Cancer Genome Atlas cancer samples and compared them with the corresponding miRNA sequencing data. Using different analytical approaches and rigorous statistical criteria, we revealed that a substantial fraction of mutations is deleterious for the proper functioning of miRNA genes affecting the level of mature miRNAs, isomiR profiles (precision of DROSHA/DICER1 cleavage), and/or 5p/3p miRNA strand balance. We also showed that most mutations, especially those identified as deleterious, destabilize the structure of miRNA precursors. The analysis showed that many miRNA gene mutations can damage miRNA genes and, if located in disease-related miRNA genes, may be pathogenic variants.

Most mutations located in miRNA genes seriously affect their proper functioning.

## Linked entities

- **Proteins:** DROSHA (drosha ribonuclease III), DICER1 (dicer 1, ribonuclease III)

## Full-text entities

- **Genes:** IDH2 (isocitrate dehydrogenase (NADP(+)) 2) [NCBI Gene 3418] {aka D2HGA2, ICD-M, IDH, IDH-2, IDHM, IDP}, TGFBR1 (transforming growth factor beta receptor 1) [NCBI Gene 7046] {aka AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1}, MIR365B (microRNA 365b) [NCBI Gene 100126356] {aka MIR365-2, MIRN365-2, hsa-mir-365b, mir-365b}, MIR518E (microRNA 518e) [NCBI Gene 574487] {aka MIRN518E, mir-518e}, MIR96 (microRNA 96) [NCBI Gene 407053] {aka DFNA50, MIRN96, hsa-mir-96, miR-96, miRNA96}, MIR2053 (microRNA 2053) [NCBI Gene 100302225] {aka hsa-mir-2053}, MIR30C1 (microRNA 30c-1) [NCBI Gene 407031] {aka MIRN30C1, mir-30c-1}, MIR16-1 (microRNA 16-1) [NCBI Gene 406950] {aka MIRN16-1, miRNA16-1, mir-16-1}, MIR142 (microRNA 142) [NCBI Gene 406934] {aka MIRN142, mir-142}, LIN28A (lin-28 RNA binding posttranscriptional regulator A) [NCBI Gene 79727] {aka CSDD1, LIN-28, LIN28, ZCCHC1, lin-28A}, MIR134 (microRNA 134) [NCBI Gene 406924] {aka MIRN134, mir-134}, MIR523 (microRNA 523) [NCBI Gene 574471] {aka MIRN523, hsa-mir-523, mir-523}, MIR140 (microRNA 140) [NCBI Gene 406932] {aka MIRN140, SEDN, miRNA140, mir-140}, MIR21 (microRNA 21) [NCBI Gene 406991] {aka MIRN21, hsa-mir-21, miR-21, miRNA21}, MIR1-1 (microRNA 1-1) [NCBI Gene 406904] {aka MIRN1-1, hsa-mir-1-1, miRNA1-1, mir-1-1}, MIR122 (microRNA 122) [NCBI Gene 406906] {aka MIR122A, MIRN122, MIRN122A, hsa-mir-122, miRNA122, miRNA122A}, MIR181A1 (microRNA 181a-1) [NCBI Gene 406995] {aka MIR213, MIRN181A1, MIRN213, hsa-mir-181a-1, mir-181a-1, mir-213}, MIR10B (microRNA 10b) [NCBI Gene 406903] {aka MIRN10B, hsa-mir-10b, miRNA10B, mir-10b}, MMP16 (matrix metallopeptidase 16) [NCBI Gene 4325] {aka C8orf57, MMP-X2, MT-MMP2, MT-MMP3, MT3-MMP}, MIR342 (microRNA 342) [NCBI Gene 442909] {aka MIRN342, hsa-mir-342}, MIR184 (microRNA 184) [NCBI Gene 406960] {aka EDICT, MIRN184, miR-184}, MIR205 (microRNA 205) [NCBI Gene 406988] {aka MIRN205, mir-205}, ASH1L (ASH1 like histone lysine methyltransferase) [NCBI Gene 55870] {aka ASH1, ASH1L1, KMT2H, MRD52}, CHN1 (chimerin 1) [NCBI Gene 1123] {aka ARHGAP2, CHN, DURS2, NC, RHOGAP2}, DROSHA (drosha ribonuclease III) [NCBI Gene 29102] {aka ETOHI2, HSA242976, RANSE3L, RN3, RNASE3L, RNASEN}, MIR379 (microRNA 379) [NCBI Gene 494328] {aka MIRN379, hsa-mir-379, mir-379}, MIR204 (microRNA 204) [NCBI Gene 406987] {aka MIRN204, RDICC, miRNA204, mir-204}, MIR15A (microRNA 15a) [NCBI Gene 406948] {aka MIRN15A, hsa-mir-15a, miRNA15A, mir-15a}, MIRLET7C (microRNA let-7c) [NCBI Gene 406885] {aka LET7C, MIRNLET7C, hsa-let-7c, let-7c}, MIR1225 (microRNA 1225) [NCBI Gene 100188847] {aka MIRN1225}, DICER1 (dicer 1, ribonuclease III) [NCBI Gene 23405] {aka DCR1, Dicer, Dicer1e, GLOW, HERNA, K12H4.8-LIKE}, MMUT (methylmalonyl-CoA mutase) [NCBI Gene 4594] {aka MCM, MUT}, HNRNPA1 (heterogeneous nuclear ribonucleoprotein A1) [NCBI Gene 3178] {aka ALS19, ALS20, HNRPA1, HNRPA1L3, IBMPFD3, MPD3}, MIR1-2 (microRNA 1-2) [NCBI Gene 406905] {aka MIRN1-2, hsa-mir-1-2, miRNA1-2, mir-1-2}, EEF1A2 (eukaryotic translation elongation factor 1 alpha 2) [NCBI Gene 1917] {aka DEE33, EEF1AL, EF-1-alpha-2, EF1A, EIEE33, HS1}, MIR320A (microRNA 320a) [NCBI Gene 407037] {aka MIRN320, MIRN320A, hsa-mir-320a, mir-320a}, RAC1 (Rac family small GTPase 1) [NCBI Gene 5879] {aka MIG5, MRD48, Rac-1, TC-25, p21-Rac1}, MIR409 (microRNA 409) [NCBI Gene 574413] {aka MIRN409, hsa-mir-409, mir-409}, KHSRP (KH-type splicing regulatory protein) [NCBI Gene 8570] {aka FBP2, FUBP2, KSRP, p75}
- **Diseases:** BLCA (MESH:D001749), glioblastoma (MESH:D005909), KIRC (MESH:D002292), ESCA (MESH:D004938), PCPG (MESH:D010673), ovarian serous cystadenocarcinoma (MESH:D010049), lymphoid neoplasm diffuse large B cell lymphoma (MESH:D016403), LIHC (MESH:D006528), skin cutaneous melanoma (MESH:C562393), UVM (MESH:C536494), MESO (MESH:D008654), THYM (MESH:D013945), B cell lymphomas (MESH:D016393), KICH (MESH:D007674), BRCA (MESH:D001943), skeletal dysplasia (MESH:C535858), retinal dystrophy (MESH:D058499), brain lower grade glioma (MESH:C564230), leukemic (MESH:D007938), THCA (MESH:D013964), UCEC (MESH:D016889), FL (MESH:D008224), COAD (MESH:D003110), nonsyndromic hearing loss (MESH:C580334), ACC (MESH:D018268), head and neck squamous cell carcinoma (MESH:D000077195), cervical squamous cell carcinoma and (MESH:D002294), blood cancers (MESH:D019337), SARC (MESH:D012509), acute myeloid leukemia (MESH:D015470), Mendelian diseases (MESH:D030342), CHOL (MESH:D018281), STAD (MESH:D013274), LUAD (MESH:D000077192), TGCT (MESH:C563236), READ (MESH:D012004), UCS (MESH:D002296), Cancer (MESH:D009369), PRAD (MESH:D000230), CLL (MESH:D015451), hereditary eye diseases (MESH:D015785), PAAD (MESH:D010190), GBM (MESH:D005910), melanoma (MESH:D008545)
- **Chemicals:** poly-A (MESH:D011061), Lipofectamine 2000 (MESH:C086724), 's (MESH:D013455), Eagle's medium (-), TRIzol (MESH:C411644)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** 38C>G, K to N, 84C>T, n.85G>A, n.-4C>T, 59T>C, n.51G>A, n.59T>C, n.97-98dupGG, n.35C>T, n.22G>T, n.-6C>G, n.94G>C, n.55A>G, 92A>C, n.16C>A, 5_7delAGC, 43G>A, n.59C>T, n.58G>C, n.30C>T, n.84C>T, 97_98dupGG, n.21-22delTA, n.59c>T, rs3746444, 55A>G, n.75C>T
- **Cell lines:** HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), HEK — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_M624), 293T — Homo sapiens (Human), Transformed cell line (CVCL_0063)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12915624/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12915624/full.md

## References

83 references — full list in the complete paper: https://tomesphere.com/paper/PMC12915624/full.md

---
Source: https://tomesphere.com/paper/PMC12915624